Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Total 13F shares
-
104,075,822
-
Share change
-
+1,209,069
-
Total reported value
-
$340,339,884
-
Put/Call ratio
-
103%
-
Price per share
-
$3.27
-
Number of holders
-
153
-
Value change
-
+$3,767,856
-
Number of buys
-
69
-
Number of sells
-
54
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2024
As of 31 Dec 2024 Arbutus Biopharma Corp - Common Shares, without par value (ABUS) had 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 104,075,822 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, Whitefort Capital Management, LP, BlackRock, Inc., VANGUARD GROUP INC, Two Seas Capital LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, BlackBarn Capital Partners LP, Rubric Capital Management LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 153 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.